We are live on ! Find out more
TCBPW

TC BioPharm (Holdings) plc Warrants
TCBPW

Delisted

TCBPW was delisted on the 21st of March, 2025.

Back to rankings

7 hedge funds and large institutions have $1.36M invested in TC BioPharm (Holdings) plc Warrants in 2022 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

41% more capital invested

Capital invested by funds: $967K → $1.36M (+$394K)

0% more funds holding

Funds holding: 7 → 7 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
7
Holders Change
–
Holders Change %
0%
% of All Funds
0.12%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
–
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$995

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
EAM
1
Empery Asset Management
New York
$653K – – –
AC
2
Armistice Capital
New York
$435K – – –
ACM
3
Altium Capital Management
New York
$118K – – –
KC
4
Kepos Capital
New York
$109K – – –
NCM
5
Nantahala Capital Management
Connecticut
$29K – – –
WAM
6
Warberg Asset Management
Illinois
$11K – – –
VF
7
Virtu Financial
New York
$6K +$995 +3,955 +18%

TCBPW Hedge Fund Activity: Q3 2022 in Review

7 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in TC BioPharm (Holdings) plc Warrants (TCBPW) for Q3 2022, worth a combined $1.36M — up 41% from $967K a quarter earlier.

Fund positioning in TCBPW was balanced in Q3 2022: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was Virtu Financial, adding an estimated $995.

  • 7 institutional investors held TC BioPharm (Holdings) plc Warrants (TCBPW) as of Q3 2022, unchanged from Q2 2022.
  • Funds reported $1.36M of TC BioPharm (Holdings) plc Warrants stock for Q3 2022, up 41% quarter-over-quarter.
  • 0 funds opened new TC BioPharm (Holdings) plc Warrants positions in Q3 2022 and 0 closed out.
  • The largest TC BioPharm (Holdings) plc Warrants buyer in Q3 2022 was Virtu Financial, an estimated $995 added.

Based on aggregated 13F filings for Q3 2022.